Key Takeaway
Complete stacking guide for CJC-1295 and tirzepatide. Learn dosing schedules, timing protocols, and how to safely combine these peptides for body composition goals.
Stacking CJC-1295 with tirzepatide combines a growth hormone-releasing hormone (GHRH) analog with a dual GIP/GLP-1 receptor agonist, targeting both growth hormone improvement and metabolic regulation simultaneously. This combination has gained attention among patients and clinicians seeking to address body composition, metabolic health, and recovery from multiple angles. Below is a thorough guide covering the rationale, protocols, and practical considerations for this stack.
Why Stack CJC-1295 and Tirzepatide?
CJC-1295, particularly the DAC (Drug Affinity Complex) variant, extends the half-life of growth hormone-releasing hormone activity, sustaining improved growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels over days rather than minutes. Tirzepatide activates both GIP and GLP-1 receptors, producing significant effects on blood sugar regulation, appetite suppression, and fat loss.
Together, these compounds address body composition through complementary mechanisms:
- CJC-1295 promotes lean muscle preservation, improved recovery, deeper sleep, and fat mobilization through the GH/IGF-1 axis.
- Tirzepatide reduces caloric intake via appetite regulation, improves insulin sensitivity, and drives fat loss through metabolic pathways independent of growth hormone.
The logic behind stacking is straightforward: tirzepatide accelerates fat loss while CJC-1295 helps preserve or build lean tissue during that process. peptide stacking
How Each Compound
CJC-1295 Overview
CJC-1295 is a synthetic analog of GHRH consisting of 29 amino acids with modifications that resist enzymatic degradation. Two forms exist in clinical and research settings: For a complete cost breakdown, see our cheapest tirzepatide options.
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
- CJC-1295 with DAC: Binds to albumin in the bloodstream, extending its half-life to approximately 6 to 8 days. This produces a sustained, steady elevation of GH.
- CJC-1295 without DAC (Mod GRF 1-29): Has a shorter half-life of roughly 30 minutes, producing a pulsatile GH release pattern that more closely mimics natural physiology.
For stacking purposes, both versions can work, though the version without DAC is more commonly paired with other peptides due to its pulsatile release pattern. CJC-1295
Tirzepatide Overview
Tirzepatide is an FDA-approved medication sold under brand names including Mounjaro and Zepbound. $1,000-$1,200/mo (brand) It's administered as a once-weekly subcutaneous injection. Dosing typically starts at 2.5 mg per week and can titrate up to 15 mg per week depending on tolerability and clinical goals.
Stacking Protocol: Step by Step
Phase 1: Baseline Establishment (Weeks 1 to 4)
Start each compound individually before combining to identify tolerability and side effects attributable to each one.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Begin tirzepatide at 2.5 mg weekly as prescribed by your physician.
- If already tolerating tirzepatide, introduce CJC-1295 (without DAC) at 100 mcg per injection, administered before bed on an empty stomach, 2 to 3 times per week.
- Monitor for GI side effects (nausea, bloating) from tirzepatide and any water retention or tingling from CJC-1295.
Phase 2: Full Stack (Weeks 5 to 12)
Once tolerability is established, move into the full protocol:
| Compound | Dose | Frequency | Timing |
|---|---|---|---|
| Tirzepatide | 5 to 10 mg (as prescribed) | Once weekly | Morning or evening, same day each week |
| CJC-1295 (no DAC) | 100 to 200 mcg | 5 days on, 2 days off | Before bed, fasted for 2+ hours |
Phase 3: Assessment and Adjustment (Week 12+)
After 12 weeks, reassess with bloodwork including:
- IGF-1 levels
- Fasting insulin and glucose
- HbA1c
- thorough metabolic panel
- Lipid panel
Adjustments should be made under medical supervision based on lab results and clinical response. peptide bloodwork
Injection Timing and Logistics
Separating injection times between the two compounds is recommended. Tirzepatide is typically injected once per week at any convenient time. CJC-1295 works best when taken before bed on an empty stomach, as natural GH secretion peaks during deep sleep.
Key timing considerations:
- Don't inject CJC-1295 within 2 hours of eating, as insulin and blood sugar spikes blunt GH release.
- Rotate injection sites between the abdomen, thigh, and upper arm to prevent lipodystrophy.
- Keep at least 4 to 6 hours between the tirzepatide injection and any CJC-1295 dose if they fall on the same day.
Expected Outcomes
When properly implemented under medical supervision, this stack may produce:
- Enhanced fat loss: Tirzepatide drives caloric deficit through appetite regulation while CJC-1295 promotes lipolysis via GH elevation.
- Lean mass preservation: GH and IGF-1 support muscle protein synthesis, counteracting the muscle loss that can accompany rapid weight reduction.
- Improved sleep quality: CJC-1295 taken before bed often enhances deep sleep stages.
- Better recovery: improved GH supports tissue repair, joint health, and exercise recovery.
- Metabolic improvements: Tirzepatide improves insulin sensitivity and glycemic control.
Side Effects to Monitor
Each compound carries its own side effect profile. Stacking doesn't necessarily compound these effects, but awareness is critical:
From Tirzepatide
- Nausea (most common, usually dose-dependent)
- Diarrhea or constipation
- Reduced appetite (intended effect but can become excessive)
- Injection site reactions
From CJC-1295
- Water retention and bloating
- Tingling or numbness in extremities
- Increased hunger (which may be offset by tirzepatide)
- Headache
One practical benefit of this stack is that tirzepatide's appetite-suppressing effects can counterbalance the increased hunger that CJC-1295 sometimes produces. peptide side effects
Who Should Avoid This Stack
This combination isn't appropriate for everyone. Contraindications include:
- Active or history of medullary thyroid carcinoma or MEN2 syndrome
- Active cancer or history of GH-sensitive tumors
- Uncontrolled diabetes without physician oversight
- Pregnancy or breastfeeding
- Severe gastrointestinal conditions such as gastroparesis
Nutrition and Training Considerations
The stack works best when paired with structured nutrition and exercise:
- Protein intake: Aim for 0.8 to 1 gram of protein per pound of body weight to support lean tissue preservation.
- Resistance training: Prioritize compound movements 3 to 4 days per week to take advantage of improved GH and IGF-1.
- Caloric management: Tirzepatide will naturally reduce appetite. Ensure caloric intake doesn't drop below levels that support basic metabolic needs and training recovery.
- Hydration: CJC-1295 can cause water retention. adequate water intake helps manage this effect.
Cost and Access
Tirzepatide is a prescription medication with significant cost considerations. From $349 CJC-1295 is available through compounding pharmacies with a prescription in many jurisdictions. The combined monthly cost of this stack can vary widely depending on tirzepatide dosing and insurance coverage. Always source peptides from licensed compounding pharmacies or FDA-approved manufacturers. compounding pharmacies
Frequently Asked Questions
- Can I inject CJC-1295 and tirzepatide on the same day?
-
Yes, you can inject both on the same day. Separate the injections by at least 4 to 6 hours and use different injection sites. Many practitioners recommend taking tirzepatide in the morning and CJC-1295 before bed.
- Should I use CJC-1295 with DAC or without DAC for this stack?
-
Most practitioners prefer CJC-1295 without DAC (Mod GRF 1-29) for stacking because it produces a more natural pulsatile GH release. The DAC version creates a sustained GH elevation that may increase the risk of side effects when combined with other compounds.
- How long should I run this stack?
-
A typical cycle runs 12 to 16 weeks, followed by bloodwork and reassessment. Tirzepatide may continue longer under physician guidance, while CJC-1295 is often cycled with breaks of 4 to 8 weeks between cycles to prevent receptor desensitization.
- Will this stack help me keep muscle while losing fat?
-
That's one of the primary rationales for this combination. Tirzepatide promotes fat loss through appetite and metabolic mechanisms, while CJC-1295 improves GH and IGF-1, which support muscle protein synthesis and lean tissue preservation during caloric deficit.
- Do I need a prescription for both compounds?
-
Tirzepatide requires a prescription in the United States and most other countries. CJC-1295 is available through compounding pharmacies with a prescription. Always work with a licensed healthcare provider and obtain these compounds through legitimate medical channels.